XML 69 R49.htm IDEA: XBRL DOCUMENT v3.25.3
Shareholders' Equity - Changes in Shareholders' Deficit (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Beginning balance     $ 423,436       $ 423,436  
Net loss $ (173,443)     $ (160,304)     (593,267) $ (659,579)
Ending balance $ (17,160)           $ (17,160)  
Common Shares                
Beginning balance (in shares) 105,782,447 102,104,024 101,221,989 92,346,332 81,807,221 81,115,723 101,221,989 81,115,723
Beginning balance $ 1,743,109 $ 1,689,346 $ 1,656,702 $ 1,298,553 $ 910,964 $ 887,528 $ 1,656,702 $ 887,528
Obligation to issue common shares as payment under license and other agreements (in shares)     222,119          
Obligation to issue common shares as payment under license and other agreements     $ 8,554          
Issuance of common shares as payment under license and other agreements (in shares)   3,588,688 132,700 154 1,872,874 97,233    
Issuance of common shares as payment under license and other agreements   $ 51,426 $ 4,844 $ 9 $ 65,981 $ 5,637    
Issuance of common shares under equity incentive plan (shares) 21,208   527,216 397,422   351,307    
Issuance of common shares under 2022 Equity Incentive Plan $ 631   $ 19,246 $ 6,758   $ 7,452    
Issuance of common shares under equity incentive plan and employee share purchase plan (in shares)   89,735     110,834      
Issuance of common shares under 2022 Equity Incentive Plan and 2022 Employee Share Purchase Plan   $ 2,337     $ 3,442      
Issuance of common shares as payment for IPR&D asset (in shares)       428 10,452 242,958    
Issuance of common shares as payment for IPR&D asset       $ 18 $ 446 $ 10,347    
Issuance of common shares, net of offering costs (in shares)       2,154,857 8,544,951      
Issuance of common shares, net of offering costs       $ 76,361 $ 317,720      
Ending balance (in shares) 105,803,655 105,782,447 102,104,024 94,899,193 92,346,332 81,807,221 105,803,655 94,899,193
Ending balance $ 1,743,740 $ 1,743,109 $ 1,689,346 $ 1,381,699 $ 1,298,553 $ 910,964 $ 1,743,740 $ 1,381,699
Additional Paid-in Capital                
Beginning balance 157,019 137,467 112,369 83,832 69,385 39,804 112,369 39,804
Obligation to issue common shares as payment under license and other agreements     (8,554)          
Issuance of common shares under 2022 Equity Incentive Plan (509)   (19,410) (2,954)   (5,296)    
Non-cash share-based compensation expense 21,535 20,812 53,062 12,160 12,232 34,877    
Issuance of common shares under 2022 Equity Incentive Plan and 2022 Employee Share Purchase Plan   (1,260)     (1,125)      
Issuance of warrant as payment under license agreement         3,340      
Ending balance 178,045 157,019 137,467 93,038 83,832 69,385 178,045 93,038
Accumulated Deficit                
Beginning balance (1,765,538) (1,567,391) (1,345,714) (998,567) (678,796) (499,292) (1,345,714) (499,292)
Net loss (173,443) (198,147) (221,677) (160,304) (319,771) (179,504)    
Ending balance (1,938,981) (1,765,538) (1,567,391) (1,158,871) (998,567) (678,796) (1,938,981) (1,158,871)
Accumulated other comprehensive income                
Beginning balance (3) 73 79 (78) (106) (65) 79 (65)
Other comprehensive income (loss) 39 (76) (6) 218 28 (41) (43) 205
Ending balance 36 (3) 73 140 (78) (106) 36 140
Total Shareholders' Equity (Deficit)                
Beginning balance 134,587 259,495 423,436 383,740 301,447 427,975 423,436 427,975
Net loss (173,443) (198,147) (221,677) (160,304) (319,771) (179,504)    
Obligation to issue common shares as payment under license and other agreements     0          
Issuance of common shares as payment under license and other agreements   51,426 4,844 9 65,981 5,637    
Issuance of common shares under 2022 Equity Incentive Plan 122   (164) 3,804   2,156    
Non-cash share-based compensation expense 21,535 20,812 53,062 12,160 12,232 34,877    
Other comprehensive income (loss) 39 (76) (6) 218 28 (41)    
Issuance of common shares under 2022 Equity Incentive Plan and 2022 Employee Share Purchase Plan   1,077     2,317      
Issuance of common shares as payment for IPR&D asset       18 446 10,347    
Issuance of common shares, net of offering costs       76,361 317,720      
Issuance of warrant as payment under license agreement         3,340      
Ending balance $ (17,160) $ 134,587 $ 259,495 $ 316,006 $ 383,740 $ 301,447 $ (17,160) $ 316,006